Polycystic ovary syndrome (PCOS) may be more common in women receiving valproic acid therapy

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1008, 2004-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Utility of Metformin Therapy in Reproductive-Aged Women with Polycystic Ovary Syndrome (PCOS)

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 1, 2014-06 ,pp. : 70-83

Bentham Science Publishers

Access to resources Recommend Favorite

Valproic acid: Polycystic ovary syndrome: case report

Reactions Weekly, Vol. 1, Iss. 1301, 2010-01 ,pp. : 51-51

Adis International

Access to resources Recommend Favorite

Simvastatin reduces serum testosterone (T) levels in women with polycystic ovary syndrome (PCOS)

Inpharma, Vol. 1, Iss. 1540, 2006-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

The ESHRE/ASRM consensus on polycystic ovary syndrome (PCOS) – an extended critical analysis

By Geisthövel Franz Rabe Thomas

Reproductive BioMedicine Online, Vol. 14, Iss. 4, 2007-04 ,pp. : 522-535

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Mediators of Low-Grade Chronic Inflammation in Polycystic Ovary Syndrome (PCOS)

Current Pharmaceutical Design, Vol. 19, Iss. 32, 2013-10 ,pp. : 5775-5791

Bentham Science Publishers

Access to resources Recommend Favorite